Phase I/II study of gefitinib (Iressa®) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00280-014-2664-9
Published Online: 2015-01-01
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Han, Ji-Youn
Lee, Soo Hyun
Lee, Geon Kook
Yun, Tak
Lee, Young Joo
Hwang, Kum Hui
Kim, Jin Young
Kim, Heung Tae
License valid from 2015-01-01